In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-15 of 15 for your search:
Drug:  thioguanine
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL01, NCT00198991

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 1 to 17
Sponsor: Other
Protocol IDs: CDR0000686545, GPOH-COALL-08-09, EUDRACT-2009-012758-18, EU-21076, NCT01228331

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: TOTXVI, 5R01CA140729, 5F32CA141762, R37CA036401, 5R01CA090246, Aspar PK-PD-T16, NCT00549848

4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: CDR0000613220, MOTOL-ALL-IC-BFM-2002, EU-20871, ALL-IC-BFM-2002, NCT00764907

5.

Phase: Phase III
Type: Treatment
Status: Active
Age: Under 18
Sponsor: Other
Protocol IDs: AIEOP-BFM ALL 2009, NCT01117441

6.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 1 to < 10
Sponsor: NCI, Other
Protocol IDs: AALL0932, NCI-2011-02599, CDR0000683227, U10CA098543, COG-AALL0932, NCT01190930

7.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: AALL1131, NCI-2011-03797, CDR0000706370, U10CA098543, COG-AALL1131, NCT01406756

8.

Phase: Phase III
Type: Treatment
Status: Active
Age: Under 18
Sponsor: Other
Protocol IDs: POWH-CRE-2008.077-T, CDR0000595184, NCT00707083

9.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 1 to 30
Sponsor: NCI
Protocol IDs: NCI-2014-00631, COG-AALL1331, AALL1331, U10CA098543, U10CA180886, NCT02101853

10.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 2 to 30
Sponsor: NCI
Protocol IDs: NCI-2014-00712, AALL1231, U10CA098543, U10CA180886, NCT02112916

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 2 to 18
Sponsor: Other
Protocol IDs: JMC-2014-6TG/6MP, NCT02141100

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 12 to 40
Sponsor: Other
Protocol IDs: 2006-0375, NCI-2012-01650, NCT00866749

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: NHL16, NCT01451515

14.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 365 days and under
Sponsor: Other
Protocol IDs: CDR0000570260, DCOG-INTERFANT-06, EUDRACT-2005-004599-19, CCLG-LK-2006-10, NCT00550992

15.

Phase: No phase specified
Type: Treatment
Status: Active
Age: Under 35
Sponsor: Other
Protocol IDs: LAL1308, GIMEMA-LAL1308, EU-21042, NCT01156883
New Search